↓ Skip to main content

The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis

Overview of attention for article published in BMC Cancer, July 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
113 Dimensions

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
Published in
BMC Cancer, July 2014
DOI 10.1186/1471-2407-14-498
Pubmed ID
Authors

Un-Ho Jin, Syng-Ook Lee, Catherine Pfent, Stephen Safe

Abstract

Patients with ER-negative breast tumors are among the most difficult to treat and exhibit low survival rates due, in part, to metastasis from the breast to various distal sites. Aryl hydrocarbon receptor (AHR) ligands show promise as antimetastatic drugs for estrogen receptor (ER)-negative breast cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 93 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 15%
Researcher 13 14%
Student > Master 7 8%
Student > Bachelor 7 8%
Student > Doctoral Student 6 6%
Other 22 24%
Unknown 24 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 19%
Agricultural and Biological Sciences 13 14%
Medicine and Dentistry 12 13%
Pharmacology, Toxicology and Pharmaceutical Science 9 10%
Chemistry 5 5%
Other 8 9%
Unknown 28 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2015.
All research outputs
#17,723,043
of 22,758,248 outputs
Outputs from BMC Cancer
#4,960
of 8,277 outputs
Outputs of similar age
#153,237
of 225,950 outputs
Outputs of similar age from BMC Cancer
#83
of 139 outputs
Altmetric has tracked 22,758,248 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,277 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,950 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 139 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.